Cell-based therapy (Pluristem Therapeutics)

细胞疗法（Pluristem Therapeutics）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCell-based therapy (Pluristem Therapeutics)
Drug Alias NamePLX-PAH
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacementsDopaminergic cell replacements
TargetsNot applicable
Therapy Area/IndicationsPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPluristem Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPluristem Therapeutics IncUnited Therapeutics Corp
Active IndicationsN/A
Inactive IndicationsPulmonary Arterial Hypertension

Other Information

ATC CodeN/A
Related LinksN/A